BICL’s CMO to present at the upcoming EULAR conference in Milan

“BICL’s CMO Dr. Roemer will present at the upcoming EULAR conference in Milan, Italy, on “How should the improvement of the joint structure be measured?” in the Session “Osteoarthritis: Challenges in the clinical study of a very prevalent disease” on June 01, 2023 13:30-14:45 CET. He will give insight in the current state of the art of imaging outcome measures in clinical DMOAD Trials and will also touch upon aNGF trials.”

Previous
Previous

Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression

Next
Next

BICL researchers first to validate MRI for osteophyte assessment